Hyaluronic acid-decorated redox-sensitive chitosan micelles for tumor-specific intracellular delivery of gambogic acid

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Zhou C, Wu Y-L, Chen G, et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncol. 2011;12(8):735–742. doi:10.1016/S1470-2045(11)70184-X21783417
   PubMed Web of Science ®Google Scholar
• Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–594. doi:10.4065/83.5.58418452692
   PubMed Web of Science ®Google Scholar
• Li C, Qi Q, Lu N, et al. Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells. Biochem Cell Biol. 2012;90(6):718–730. doi:10.1139/o2012-03023194187
   PubMedGoogle Scholar
• Zhu X, Zhang H, Lin Y, et al. Mechanisms of gambogic acid-induced apoptosis in non-small cell lung cancer cells in relation to transferrin receptors. J Chemother. 2009;21(6):666–672. doi:10.1179/joc.2009.21.6.66620071291
   PubMed Web of Science ®Google Scholar
• Wang X, Deng R, Lu Y, et al. Gambogic acid as a non-competitive inhibitor of ATP-binding cassette transporter B1 reverses the multidrug resistance of human epithelial cancers by promoting ATP-binding cassette transporter B1 protein degradation. Basic Clin Pharmacol Toxicol. 2013;113(1):25–33. doi:10.1111/bcpt.1205823398656
   PubMedGoogle Scholar
• Banik K, Harsha C, Bordoloi D, et al. Therapeutic potential of gambogic acid, a caged xanthone, to target cancer. Cancer Lett. 2018;416:75–86. doi:10.1016/j.canlet.2017.12.01429246645
   PubMed Web of Science ®Google Scholar
• Chi Y, Zhang XK, Yu H, et al. An open-labeled, randomized, multicenter phase IIa study of gambogic acid injection for advanced malignant tumors. Chin Med J (Engl). 2013;126(9):1642–1646.23652044
   PubMed Web of Science ®Google Scholar
• Wang X, Chen W. Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis. Anticancer Agents Med Chem. 2012;12(8):994–1000.22339063
   PubMed Web of Science ®Google Scholar
• Ishaq M, Khan MA, Sharma K, Sharma G, Dutta RK, Majumdar S. Gambogic acid induced oxidative stress dependent caspase activation regulates both apoptosis and autophagy by targeting various key molecules (NF-kappaB, Beclin-1, p62 and NBR1) in human bladder cancer cells. Biochim Biophys Acta. 2014;1840(12):3374–3384. doi:10.1016/j.bbagen.2014.08.01925218692
   PubMed Web of Science ®Google Scholar
• Wang S, Wang L, Chen M, Wang Y. Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression. Chem Biol Interact. 2015;235:76–84. doi:10.1016/j.cbi.2015.03.01725824409
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang S, Chan HF, et al. Triphenylphosphonium-modified poly(ethylene glycol)-poly(epsilon-caprolactone) micelles for mitochondria- targeted gambogic acid delivery. Int J Pharm. 2017;522(1–2):21–33. doi:10.1016/j.ijpharm.2017.01.06428215509
   PubMed Web of Science ®Google Scholar
• Yin T, Wang L, Yin L, Zhou J, Huo M. Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer. Biomaterials. 2015;61:10–25. doi:10.1016/j.biomaterials.2015.05.02225996409
   PubMed Web of Science ®Google Scholar
• Shi S, Shi K, Tan L, et al. The use of cationic MPEG-PCL-g-PEI micelles for co-delivery of Msurvivin T34A gene and doxorubicin. Biomaterials. 2014;35(15):4536–4547. doi:10.1016/j.biomaterials.2014.02.01024582554
   PubMed Web of Science ®Google Scholar
• Li J, Huo M, Wang J, et al. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials. 2012;33(7):2310–2320. doi:10.1016/j.biomaterials.2011.11.02222166223
   PubMed Web of Science ®Google Scholar
• Yang X, Cai X, Yu A, Xi Y, Zhai G. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel. J Colloid Interface Sci. 2017;496:311–326. doi:10.1016/j.jcis.2017.02.03328237749
   PubMed Web of Science ®Google Scholar
• Raja MA, Arif M, Feng C, Zeenat S, Liu CG. Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers. J Biomater Appl. 2017;31(8):1182–1195. doi:10.1177/088532821668118428081668
   PubMedGoogle Scholar
• Li N, Cai H, Jiang L, et al. Enzyme-sensitive and amphiphilic PEGylated dendrimer-paclitaxel prodrug-based nanoparticles for enhanced stability and anticancer efficacy. ACS Appl Mater Interfaces. 2017;9(8):6865–6877. doi:10.1021/acsami.6b1550528112512
   PubMed Web of Science ®Google Scholar
• Huu VA, Luo J, Zhu J, et al. Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye. J Control Release. 2015;200:71–77. doi:10.1016/j.jconrel.2015.01.00125571784
   PubMed Web of Science ®Google Scholar
• Yamazaki N, Sugimoto T, Fukushima M, et al. Dual-stimuli responsive liposomes using pH- and temperature-sensitive polymers for controlled transdermal delivery. Polym Chem. 2017;8(9):1507–1518. doi:10.1039/C6PY01754A
   Web of Science ®Google Scholar
• Tabatabaei SN, Girouard H, Carret AS, Martel S. Remote control of the permeability of the blood-brain barrier by magnetic heating of nanoparticles: a proof of concept for brain drug delivery. J Control Release. 2015;206:49–57. doi:10.1016/j.jconrel.2015.02.02725724273
   PubMed Web of Science ®Google Scholar
• Bae YJ, Yoon YI, Yoon TJ, Lee HJ. Ultrasound-guided delivery of siRNA and a chemotherapeutic drug by using microbubble complexes: in vitro and in vivo evaluations in a prostate cancer model. Korean J Radiol. 2016;17(4):497–508. doi:10.3348/kjr.2016.17.4.49727390541
   PubMedGoogle Scholar
• Sabu C, Rejo C, Kotta S, Pramod K. Bioinspired and biomimetic systems for advanced drug and gene delivery. J Control Release. 2018;287:142–155. doi:10.1016/j.jconrel.2018.08.03330165138
   PubMed Web of Science ®Google Scholar
• Ramasamy T, Ruttala HB, Gupta B, et al. Smart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive review. J Control Release. 2017;258:226–253. doi:10.1016/j.jconrel.2017.04.04328472638
   PubMed Web of Science ®Google Scholar
• Yin T, Wu Q, Wang L, Yin L, Zhou J, Huo M. Well-defined redox-sensitive polyethene glycol-paclitaxel prodrug conjugate for tumor-specific delivery of paclitaxel using octreotide for tumor targeting. Mol Pharm. 2015;12(8):3020–3031. doi:10.1021/acs.molpharmaceut.5b0028026086430
   PubMedGoogle Scholar
• Huo M, Liu Y, Wang L, et al. Redox-sensitive micelles based on O,N-hydroxyethyl chitosan-octylamine conjugates for triggered intracellular delivery of paclitaxel. Mol Pharm. 2016;13(6):1750–1762. doi:10.1021/acs.molpharmaceut.5b0069627100204
   PubMedGoogle Scholar
• Yin T, Liu J, Zhao Z, et al. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties. J Control Release. 2016;243:54–68. doi:10.1016/j.jconrel.2016.09.03627702595
   PubMed Web of Science ®Google Scholar
• Ito T, Koyama Y, Otsuka M. Analysis of the surface structure of DNA/polycation/hyaluronic acid ternary complex by Raman microscopy. J Pharm Biomed Anal. 2010;51(1):268–272. doi:10.1016/j.jpba.2009.07.02419692196
   PubMedGoogle Scholar
• Zhong Y, Zhang J, Cheng R, et al. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. J Control Release. 2015;205:144–154. doi:10.1016/j.jconrel.2015.01.01225596560
   PubMed Web of Science ®Google Scholar
• Dosio F, Arpicco S, Stella B, Fattal E. Hyaluronic acid for anticancer drug and nucleic acid delivery. Adv Drug Deliv Rev. 2016;97:204–236. doi:10.1016/j.addr.2015.11.01126592477
   PubMed Web of Science ®Google Scholar
• Huo M, Zou A, Yao C, et al. Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles. Biomaterials. 2012;33(27):6393–6407. doi:10.1016/j.biomaterials.2012.05.05222704599
   PubMed Web of Science ®Google Scholar
• Li H, Huo M, Zhou J, et al. Enhanced oral absorption of paclitaxel in N-deoxycholic acid-N, O-hydroxyethyl chitosan micellar system. J Pharm Sci. 2010;99(11):4543–4553. doi:10.1002/jps.2215920845453
   PubMed Web of Science ®Google Scholar
• Moyuan C, Haixia J, Weijuan Y, Peng L, Liqun W, Hongliang J. A convenient scheme for synthesizing reduction-sensitive chitosan-based amphiphilic copolymers for drug delivery. J Appl Polym Sci. 2012;123(5):3137–3144.
   Web of Science ®Google Scholar
• Luo Y, Prestwich GD. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjugate Chem. 1999;10(5):755−63. doi:10.1021/bc9900338
   PubMed Web of Science ®Google Scholar
• Li Z, Liu R, Mai B, et al. Temperature-induced and crystallization-driven self-assembly of polyethylene-b-poly(ethylene oxide) in solution. Polymer. 2013;54(6):1663–1670. doi:10.1016/j.polymer.2013.01.044
   Web of Science ®Google Scholar
• Hou L, Yao J, Zhou J, Zhang Q. Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system. Biomaterials. 2012;33(21):5431–5440. doi:10.1016/j.biomaterials.2012.03.07022521488
   PubMed Web of Science ®Google Scholar
• Wang X, Ouyang X, Chen J, Hu Y, Sun X, Yu Z. Nanoparticulate photosensitizer decorated with hyaluronic acid for photodynamic/photothermal cancer targeting therapy. Nanomedicine. 2019;14(2):151–167. doi:10.2217/nnm-2018-020430511886
   PubMed Web of Science ®Google Scholar
• Ramasamy T, Tran TH, Choi J, et al. Layer-by-layer coated lipid–polymer hybrid nanoparticles designedfor use in anticancer drug delivery. Carbohydr Polym. 2014;102:653–661. doi:10.1016/j.carbpol.2013.10.04824507332
   PubMed Web of Science ®Google Scholar